Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 21, 2021

SELL
$29.09 - $45.68 $177,449 - $278,648
-6,100 Closed
0 $0
Q2 2021

Aug 13, 2021

BUY
$32.46 - $40.48 $198,006 - $246,927
6,100 New
6,100 $237,000
Q1 2021

Apr 30, 2021

SELL
$33.61 - $49.95 $174,772 - $259,740
-5,200 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$26.52 - $49.35 $137,904 - $256,620
5,200 New
5,200 $236,000
Q3 2019

Oct 22, 2019

SELL
$31.84 - $50.88 $133,728 - $213,696
-4,200 Closed
0 $0
Q2 2019

Jul 26, 2019

BUY
$42.0 - $59.29 $176,400 - $249,018
4,200 New
4,200 $216,000

Others Institutions Holding RGNX

About REGENXBIO Inc.


  • Ticker RGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,230,000
  • Market Cap $329M
  • Description
  • REGENXBIO Inc., a clinical-stage biotechnology company, provides gene therapy product candidates to deliver genes to cells to address genetic defects or to enable cells in the body to produce therapeutic proteins or antibodies that are intended to impact disease. Its gene therapy product candidates are based on NAV Technology Platform, a proprie...
More about RGNX
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.